Travere Therapeutics Inc
NASDAQ:TVTX
Wall Street
Price Targets
TVTX Price Targets Summary
Travere Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
TVTX
is 15.23 USD
with a low forecast of 9.09 USD and a high forecast of 22.05 USD.
TVTX Last Price Targets
Travere Therapeutics Inc
The latest public price target was made on Apr 24, 2024 by
Ed Arce
from
H.C. Wainwright
,
who expects
TVTX
stock to
rise by 204%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Ed Arce
H.C. Wainwright
|
19
USD
Upside 204% |
1 week ago
Apr 24, 2024
|
Travere Therapeutics price target raised to $19 from $17 at H.C. Wainwright
TheFly
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TVTX's stock price target?
Price Target
15.23
USD
According to Wall Street analysts, the average 1-year price target for
TVTX
is 15.23 USD
with a low forecast of 9.09 USD and a high forecast of 22.05 USD.
What is Travere Therapeutics Inc's Revenue forecast?
Projected CAGR
45%
For the last 8 years the
compound annual growth rate for
Travere Therapeutics Inc's revenue is
5%.
The projected
CAGR
for the next 3 years is
45%.
You don't have any saved screeners yet
